The Rotterdam pilot studies. Int J Cancer 65: 145*151, 1996.Gomez-Gomez E, Carrasco-Valiente J, Blanca-Pedregosa A, et al. European Randomized Study of Screening for Prostate Cancer risk calculator: external validation, variability, and clinical significance. Urology. 2017;102:85-91....
Prostate-Specific Antigen–Based Screening for Prostate Cancer: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 154. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05229-EF-1. 4. Fenton JJ, Weyrich MS, Durbin ...
Is there evidence that use of a prebiopsy prostate cancer risk calculator, in combination with PSA-based screening, accurately identifies men with clinically significant prostate cancer compared with PSA-based screening alone? Fourteen articles (n = 48 234)12-14,89-99 provided evidence on ...
Text size:AAA RU PL LT EE EN NL In partnership with the European Randomized Study of Screening for Prostate Cancer News in Brief No announcement available No announcement available Calculate your prostate cancer risk A practical, private and simple way of assessing your personal risk ...
The first version of the Prostate Cancer Risk Calculator, developed in 2006 to help men and their doctors assess their risk for prostate cancer, has been completely revamped. Version 2.0 uses current risk factors and gives a more nuanced result to help a man and his physician understand the ...
Prostate cancer risk assessmentPCPT risk calculatorAge and race-specific reference rangesWhile the current value of prostate cancer screening in reducing mortality is debatable, there is no doubt that screening has created overdetection of clinically insignificant cancers. An......
Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: A Performance Comparison in a Contemporar... The online European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator may aid in the decision to perform prostate biopsy...
Prostate cancer: ERSPC calculator recalibrated for Chinadoi:10.1038/nrurol.2016.259FennerAnnetteNature Reviews UrologyFenner A. Prostate cancer: ERSPC calculator re- calibrated for China. Nat Rev Urol 2017; 14: 66.
The Prostate Cancer Prevention Trial (PCPT) Prostate Cancer Risk Calculator provides a single probability of prostate cancer and of high-grade disease (Gleason grade \(\geq\) 7) based on a man's serum prostate-specific antigen (PSA) level, digital rectal examination (DRE) result, family histor...
presentation, [68Ga]Ga-PSMA-11 PET/CT demonstrated higher diagnostic efficacy for PI-RADS 3 score patients and had an advantage over the european randomized study of screening for prostate cancer risk calculator 3 (ERSPC-RC3) and prostate cancer prevention trial risk calculator (PCPT-RC) models...